80 related articles for article (PubMed ID: 36328739)
1. Declining melatonin levels and MT1 receptor expression in aging rats is associated with enhanced mammary tumor growth and decreased sensitivity to melatonin.
Hill SM; Cheng C; Yuan L; Mao L; Jockers R; Dauchy B; Frasch T; Blask DE
Breast Cancer Res Treat; 2011 May; 127(1):91-8. PubMed ID: 20549340
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effects of melatonin on boar sperm motility and kinematics are mediated by MT1 receptor.
Yang D; Wang C; Lu W; Tian X; Sun Y; Peng H
Theriogenology; 2024 Jun; 226():95-103. PubMed ID: 38870584
[TBL] [Abstract][Full Text] [Related]
3. Regulation of L1 expression and retrotransposition by melatonin and its receptor: implications for cancer risk associated with light exposure at night.
deHaro D; Kines KJ; Sokolowski M; Dauchy RT; Streva VA; Hill SM; Hanifin JP; Brainard GC; Blask DE; Belancio VP
Nucleic Acids Res; 2014 Jul; 42(12):7694-707. PubMed ID: 24914052
[TBL] [Abstract][Full Text] [Related]
4. Retraction Note: Declining melatonin levels and MT1 receptor expression in aging rats is associated with enhanced mammary tumor growth and decreased sensitivity to melatonin.
Hill SM; Cheng C; Yuan L; Mao L; Jockers R; Dauchy B; Frasch T; Blask DE
Breast Cancer Res Treat; 2024 Apr; ():. PubMed ID: 38607596
[No Abstract] [Full Text] [Related]
5. Pharmacological inhibition of the ubiquitin-specific protease 8 effectively suppresses glioblastoma cell growth.
Long Y; Hu Z; Yang D; Wang F; Zhao C; Zhang Y; Zhang Y; Ma H; Lv H
Open Life Sci; 2023; 18(1):20220562. PubMed ID: 36816802
[TBL] [Abstract][Full Text] [Related]
6. Biomolecular Liquid-Liquid Phase Separation for Biotechnology.
Shil S; Tsuruta M; Kawauchi K; Miyoshi D
BioTech (Basel); 2023 Apr; 12(2):. PubMed ID: 37092470
[TBL] [Abstract][Full Text] [Related]
7. Liquid-liquid phase separation: Galectin-3 in nuclear speckles and ribonucleoprotein complexes.
Voss PG; Wang JL
Exp Cell Res; 2023 Jun; 427(1):113571. PubMed ID: 37003559
[TBL] [Abstract][Full Text] [Related]
8. Clinically relevant stratification of lung squamous carcinoma patients based on ubiquitinated proteasome genes for 3P medical approach.
Yang J; Ouedraogo SY; Wang J; Li Z; Feng X; Ye Z; Zheng S; Li N; Zhan X
EPMA J; 2024 Mar; 15(1):67-97. PubMed ID: 38463626
[TBL] [Abstract][Full Text] [Related]
9. The deubiquitylating enzyme USP35 restricts regulated cell death to promote survival of renal clear cell carcinoma.
Wang S; Wang T; Zhang X; Cheng S; Chen C; Yang G; Wang F; Wang R; Zhang Q; Yang D; Zhang Y; Liu S; Qin H; Liu Q; Liu H
Cell Death Differ; 2023 Jul; 30(7):1757-1770. PubMed ID: 37173391
[TBL] [Abstract][Full Text] [Related]
10. Human amniotic epithelial cells express melatonin receptor MT1, but not melatonin receptor MT2: a new perspective to neuroprotection.
Kaneko Y; Hayashi T; Yu S; Tajiri N; Bae EC; Solomita MA; Chheda SH; Weinbren NL; Parolini O; Borlongan CV
J Pineal Res; 2011 Apr; 50(3):272-80. PubMed ID: 21269327
[TBL] [Abstract][Full Text] [Related]
11. [MT1 melatonin receptors and their role in the oncostatic action of melatonin].
Danielczyk K; Dziegiel P
Postepy Hig Med Dosw (Online); 2009 Sep; 63():425-34. PubMed ID: 19837985
[TBL] [Abstract][Full Text] [Related]
12. Functional MT1 and MT2 melatonin receptors in mammals.
Dubocovich ML; Markowska M
Endocrine; 2005 Jul; 27(2):101-10. PubMed ID: 16217123
[TBL] [Abstract][Full Text] [Related]
13. The ubiquitin-specific protease 8 antagonizes melatonin-induced endocytic degradation of MT
Sun Q; Zhang J; Li X; Yang G; Cheng S; Guo D; Zhang Q; Sun F; Zhao F; Yang D; Wang S; Wang T; Liu S; Zou L; Zhang Y; Liu H
J Adv Res; 2022 Nov; 41():1-12. PubMed ID: 36328739
[TBL] [Abstract][Full Text] [Related]
14. Gender-related invasion differences associated with mRNA expression levels of melatonin membrane receptors in colorectal cancer.
León J; Casado J; Carazo A; Sanjuán L; Maté A; Muñoz de Rueda P; de la Cueva P; Quiles R; Ruíz S; Ruíz-Extremera A; Salmerón J
Mol Carcinog; 2012 Aug; 51(8):608-18. PubMed ID: 21809392
[TBL] [Abstract][Full Text] [Related]
15. MT1 and MT2 melatonin receptors play opposite roles in brain cancer progression.
Kinker GS; Ostrowski LH; Ribeiro PAC; Chanoch R; Muxel SM; Tirosh I; Spadoni G; Rivara S; Martins VR; Santos TG; Markus RP; Fernandes PACM
J Mol Med (Berl); 2021 Feb; 99(2):289-301. PubMed ID: 33392634
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
